The Need for Continuing Blinded Pose- and Activity Prediction Benchmarks

. 2025 Mar 10 ; 65 (5) : 2180-2190. [epub] 20250214

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid39951479

Grantová podpora
R35 GM148236 NIGMS NIH HHS - United States

Computational tools for structure-based drug design (SBDD) are widely used in drug discovery and can provide valuable insights to advance projects in an efficient and cost-effective manner. However, despite the importance of SBDD to the field, the underlying methodologies and techniques have many limitations. In particular, binding pose and activity predictions (P-AP) are still not consistently reliable. We strongly believe that a limiting factor is the lack of a widely accepted and established community benchmarking process that independently assesses the performance and drives the development of methods, similar to the CASP benchmarking challenge for protein structure prediction. Here, we provide an overview of P-AP, unblinded benchmarking data sets, and blinded benchmarking initiatives (concluded and ongoing) and offer a perspective on learnings and the future of the field. To accelerate a breakthrough on the development of novel P-AP methods, it is necessary for the community to establish and support a long-term benchmark challenge that provides nonbiased training/test/validation sets, a systematic independent validation, and a forum for scientific discussions.

Zobrazit více v PubMed

van Montfort RLM; Workman P Structure-Based Drug Design: Aiming for a Perfect Fit. Essays Biochem. 2017, 61 (5), 431–437. 10.1042/EBC20170052. PubMed DOI PMC

Bissantz C; Kuhn B; Stahl M A Medicinal Chemist’s Guide to Molecular Interactions. J. Med. Chem. 2010, 53 (14), 5061–5084. 10.1021/jm100112j. PubMed DOI PMC

Cournia Z; Allen B; Sherman W Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations. J. Chem. Inf. Model. 2017, 57 (12), 2911–2937. 10.1021/acs.jcim.7b00564. PubMed DOI

Feng M; Heinzelmann G; Gilson MK Absolute Binding Free Energy Calculations Improve Enrichment of Actives in Virtual Compound Screening. Sci. Rep. 2022, 12 (1), 13640. 10.1038/s41598-022-17480-w. PubMed DOI PMC

Wang L; Wu Y; Deng Y; Kim B; Pierce L; Krilov G; Lupyan D; Robinson S; Dahlgren MK; Greenwood J; Romero DL; Masse C; Knight JL; Steinbrecher T; Beuming T; Damm W; Harder E; Sherman W; Brewer M; Wester R; Murcko M; Frye L; Farid R; Lin T; Mobley DL; Jorgensen WL; Berne BJ; Friesner RA; Abel R Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field. J. Am. Chem. Soc. 2015, 137 (7), 2695–2703. 10.1021/ja512751q. PubMed DOI

Sivula T; Yetukuri L; Kalliokoski T; Käsnänen H; Poso A; Pöhner I Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries. J. Chem. Inf. Model. 2023, 63 (18), 5773–5783. 10.1021/acs.jcim.3c01239. PubMed DOI PMC

Chen W; Cui D; Abel R; Friesner RA; Wang L Accurate Calculation of Absolute Protein-Ligand Binding Free Energies. ChemRxiv April 13, 2022. 10.26434/chemrxiv-2022-2t0dq. DOI

Zev S; Raz K; Schwartz R; Tarabeh R; Gupta PK; Major DT Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro. J. Chem. Inf. Model. 2021, 61 (6), 2957–2966. 10.1021/acs.jcim.1c00263. PubMed DOI

Gathiaka S; Liu S; Chiu M; Yang H; Stuckey JA; Kang YN; Delproposto J; Kubish G; Dunbar JB; Carlson HA; Burley SK; Walters WP; Amaro RE; Feher VA; Gilson MK D3R Grand Challenge 2015: Evaluation of Protein–Ligand Pose and Affinity Predictions. J. Comput. Aided Mol. Des. 2016, 30 (9), 651–668. 10.1007/s10822-016-9946-8. PubMed DOI PMC

Jansen JM; Cornell W; Tseng YJ; Amaro RE Teach–Discover–Treat (TDT): Collaborative Computational Drug Discovery for Neglected Diseases. J. Mol. Graph. Model. 2012, 38, 360–362. 10.1016/j.jmgm.2012.07.007. PubMed DOI PMC

Haas J; Barbato A; Behringer D; Studer G; Roth S; Bertoni M; Mostaguir K; Gumienny R; Schwede T Continuous Automated Model EvaluatiOn (CAMEO) Complementing the Critical Assessment of Structure Prediction in CASP12. Proteins Struct. Funct. Bioinforma. 2018, 86 (S1), 387–398. 10.1002/prot.25431. PubMed DOI PMC

Mullard A When Can AI Deliver the Drug Discovery Hits? Nat. Rev. Drug Discov. 2024, 23 (3), 159–161. 10.1038/d41573-024-00036-0. PubMed DOI

Wagner JR; Churas CP; Liu S; Swift RV; Chiu M; Shao C; Feher VA; Burley SK; Gilson MK; Amaro RE Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking. Structure 2019, 27 (8), 1326–1335.e4. 10.1016/j.str.2019.05.012. PubMed DOI PMC

Kryshtafovych A; Antczak M; Szachniuk M; Zok T; Kretsch RC; Rangan R; Pham P; Das R; Robin X; Studer G; Durairaj J; Eberhardt J; Sweeney A; Topf M; Schwede T; Fidelis K; Moult J New Prediction Categories in CASP15. Proteins Struct. Funct. Bioinforma. 2023, 91 (12), 1550–1557. 10.1002/prot.26515. PubMed DOI PMC

Klauda JB Virtual Issue on Docking. J. Phys. Chem. B 2021, 125 (21), 5455–5457. 10.1021/acs.jpcb.1c03303. PubMed DOI

Jiang D; Zhao H; Du H; Deng Y; Wu Z; Wang J; Zeng Y; Zhang H; Wang X; Wu J; Hsieh C-Y; Hou T How Good Are Current Docking Programs at Nucleic Acid–Ligand Docking? A Comprehensive Evaluation. J. Chem. Theory Comput. 2023, 19 (16), 5633–5647. 10.1021/acs.jctc.3c00507. PubMed DOI

Elokely KM; Doerksen RJ Docking Challenge: Protein Sampling and Molecular Docking Performance. J. Chem. Inf. Model. 2013, 53 (8), 1934–1945. 10.1021/ci400040d. PubMed DOI PMC

Kuntz ID; Blaney JM; Oatley SJ; Langridge R; Ferrin TE A Geometric Approach to Macromolecule-Ligand Interactions. J. Mol. Biol. 1982, 161 (2), 269–288. 10.1016/0022-2836(82)90153-X. PubMed DOI

Trott O; Olson AJ AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. J. Comput. Chem. 2010, 31 (2), 455–461. 10.1002/jcc.21334. PubMed DOI PMC

Böhm HJ The Computer Program LUDI: A New Method for the de Novo Design of Enzyme Inhibitors. J. Comput. Aided Mol. Des. 1992, 6 (1), 61–78. 10.1007/BF00124387. PubMed DOI

Abagyan R; Totrov M; Kuznetsov D ICM—A New Method for Protein Modeling and Design: Applications to Docking and Structure Prediction from the Distorted Native Conformation. J. Comput. Chem. 1994, 15 (5), 488–506. 10.1002/jcc.540150503. DOI

Jones G; Willett P; Glen RC; Leach AR; Taylor R Development and Validation of a Genetic Algorithm for Flexible Docking1. J. Mol. Biol. 1997, 267 (3), 727–748. 10.1006/jmbi.1996.0897. PubMed DOI

Kramer B; Rarey M; Lengauer T Evaluation of the FLEXX Incremental Construction Algorithm for Protein–Ligand Docking. Proteins Struct. Funct. Bioinforma. 1999, 37 (2), 228–241. 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8. PubMed DOI

Friesner RA; Banks JL; Murphy RB; Halgren TA; Klicic JJ; Mainz DT; Repasky MP; Knoll EH; Shelley M; Perry JK; Shaw DE; Francis P; Shenkin PS Glide:  A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem. 2004, 47 (7), 1739–1749. 10.1021/jm0306430. PubMed DOI

McGann M FRED and HYBRID Docking Performance on Standardized Datasets. J. Comput. Aided Mol. Des. 2012, 26 (8), 897–906. 10.1007/s10822-012-9584-8. PubMed DOI

Corso G; Stärk H; Jing B; Barzilay R; Jaakkola T DiffDock: Diffusion Steps, Twists, and Turns for Molecular Docking. arXiv February 11, 2023. 10.48550/arXiv.2210.01776. DOI

Stärk H; Ganea O; Pattanaik L; Barzilay DR; Jaakkola T EquiBind: Geometric Deep Learning for Drug Binding Structure Prediction. In Proceedings of the 39th International Conference on Machine Learning; PMLR, 2022; pp 20503–20521.

Buttenschoen M; Morris GM; Deane CM PoseBusters: AI-Based Docking Methods Fail to Generate Physically Valid Poses or Generalise to Novel Sequences. Chem. Sci. 2024, 15 (9), 3130–3139. 10.1039/D3SC04185A. PubMed DOI PMC

Irwin JJ; Shoichet BK Docking Screens for Novel Ligands Conferring New Biology. J. Med. Chem. 2016, 59 (9), 4103–4120. 10.1021/acs.jmedchem.5b02008. PubMed DOI PMC

Godschalk F; Genheden S; Söderhjelm P; Ryde U Comparison of MM/GBSA Calculations Based on Explicit and Implicit Solvent Simulations. Phys. Chem. Chem. Phys. 2013, 15 (20), 7731–7739. 10.1039/C3CP00116D. PubMed DOI

Åqvist J; Medina C; Samuelsson J-E A New Method for Predicting Binding Affinity in Computer-Aided Drug Design. Protein Eng. Des. Sel. 1994, 7 (3), 385–391. 10.1093/protein/7.3.385. PubMed DOI

Hou T; Wang J; Li Y; Wang W Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations. J. Chem. Inf. Model. 2011, 51 (1), 69–82. 10.1021/ci100275a. PubMed DOI PMC

Bhati AP; Wan S; Wright DW; Coveney PV Rapid, Accurate, Precise, and Reliable Relative Free Energy Prediction Using Ensemble Based Thermodynamic Integration. J. Chem. Theory Comput. 2017, 13 (1), 210–222. 10.1021/acs.jctc.6b00979. PubMed DOI

Ross GA; Lu C; Scarabelli G; Albanese SK; Houang E; Abel R; Harder ED; Wang L The Maximal and Current Accuracy of Rigorous Protein-Ligand Binding Free Energy Calculations. Commun. Chem. 2023, 6 (1), 1–12. 10.1038/s42004-023-01019-9. PubMed DOI PMC

Gilson MK; Stewart LE; Potter MJ; Webb SP Rapid, Accurate, Ranking of Protein–Ligand Binding Affinities with VM2, the Second-Generation Mining Minima Method. J. Chem. Theory Comput. 2024, 20 (14), 6328–6340. 10.1021/acs.jctc.4c00407. PubMed DOI PMC

Ginex T; Vázquez J; Estarellas C; Luque FJ Quantum Mechanical-Based Strategies in Drug Discovery: Finding the Pace to New Challenges in Drug Design. Curr. Opin. Struct. Biol. 2024, 87, 102870. 10.1016/j.sbi.2024.102870. PubMed DOI

Fedorov DG The Fragment Molecular Orbital Method: Theoretical Development, Implementation in GAMESS, and Applications. WIREs Comput. Mol. Sci. 2017, 7 (6), e1322. 10.1002/wcms.1322. DOI

Pecina A; Fanfrlík J; Lepšík M; Řezáč J SQM2.20: Semiempirical Quantum-Mechanical Scoring Function Yields DFT-Quality Protein–Ligand Binding Affinity Predictions in Minutes. Nat. Commun. 2024, 15 (1), 1127. 10.1038/s41467-024-45431-8. PubMed DOI PMC

Jorgensen WL The Many Roles of Computation in Drug Discovery. Science 2004, 303 (5665), 1813–1818. 10.1126/science.1096361. PubMed DOI

Charifson PS; Corkery JJ; Murcko MA; Walters WP Consensus Scoring:  A Method for Obtaining Improved Hit Rates from Docking Databases of Three-Dimensional Structures into Proteins. J. Med. Chem. 1999, 42 (25), 5100–5109. 10.1021/jm990352k. PubMed DOI

Warren GL; Andrews CW; Capelli A-M; Clarke B; LaLonde J; Lambert MH; Lindvall M; Nevins N; Semus SF; Senger S; Tedesco G; Wall ID; Woolven JM; Peishoff CE; Head MS A Critical Assessment of Docking Programs and Scoring Functions. J. Med. Chem. 2006, 49 (20), 5912–5931. 10.1021/jm050362n. PubMed DOI

Méndez-Lucio O; Ahmad M; del Rio-Chanona EA; Wegner JK A Geometric Deep Learning Approach to Predict Binding Conformations of Bioactive Molecules. Nat. Mach. Intell. 2021, 3 (12), 1033–1039. 10.1038/s42256-021-00409-9. DOI

Zhou G; Gao Z; Ding Q; Zheng H; Xu H; Wei Z; Zhang L; Ke G Uni-Mol: A Universal 3D Molecular Representation Learning Framework. ChemRxiv May 26, 2022. 10.26434/chemrxiv-2022-jjm0j. DOI

Lu W; Wu Q; Zhang J; Rao J; Li C; Zheng S TANKBind: Trigonometry-Aware Neural NetworKs for Drug-Protein Binding Structure Prediction. bioRxiv June 6, 2022, p 2022.06.06.495043. 10.1101/2022.06.06.495043. DOI

Abramson J; Adler J; Dunger J; Evans R; Green T; Pritzel A; Ronneberger O; Willmore L; Ballard AJ; Bambrick J; Bodenstein SW; Evans DA; Hung C-C; O’Neill M; Reiman D; Tunyasuvunakool K; Wu Z; Žemgulytė A; Arvaniti E; Beattie C; Bertolli O; Bridgland A; Cherepanov A; Congreve M; Cowen-Rivers AI; Cowie A; Figurnov M; Fuchs FB; Gladman H; Jain R; Khan YA; Low CMR; Perlin K; Potapenko A; Savy P; Singh S; Stecula A; Thillaisundaram A; Tong C; Yakneen S; Zhong ED; Zielinski M; Žídek A; Bapst V; Kohli P; Jaderberg M; Hassabis D; Jumper JM Accurate Structure Prediction of Biomolecular Interactions with AlphaFold 3. Nature 2024, 630 (8016), 493–500. 10.1038/s41586-024-07487-w. PubMed DOI PMC

Jumper J; Evans R; Pritzel A; Green T; Figurnov M; Ronneberger O; Tunyasuvunakool K; Bates R; Žídek A; Potapenko A; Bridgland A; Meyer C; Kohl SAA; Ballard AJ; Cowie A; Romera-Paredes B; Nikolov S; Jain R; Adler J; Back T; Petersen S; Reiman D; Clancy E; Zielinski M; Steinegger M; Pacholska M; Berghammer T; Bodenstein S; Silver D; Vinyals O; Senior AW; Kavukcuoglu K; Kohli P; Hassabis D Highly Accurate Protein Structure Prediction with AlphaFold. Nature 2021, 596 (7873), 583–589. 10.1038/s41586-021-03819-2. PubMed DOI PMC

Qiao Z; Nie W; Vahdat A; Miller TF; Anandkumar A State-Specific Protein–Ligand Complex Structure Prediction with a Multiscale Deep Generative Model. Nat. Mach. Intell. 2024, 6 (2), 195–208. 10.1038/s42256-024-00792-z. DOI

Krishna R; Wang J; Ahern W; Sturmfels P; Venkatesh P; Kalvet I; Lee GR; Morey-Burrows FS; Anishchenko I; Humphreys IR; McHugh R; Vafeados D; Li X; Sutherland GA; Hitchcock A; Hunter CN; Kang A; Brackenbrough E; Bera AK; Baek M; DiMaio F; Baker D Generalized Biomolecular Modeling and Design with RoseTTAFold All-Atom. Science 2024, 384 (6693), eadl2528. 10.1126/science.adl2528. PubMed DOI

Chen L; Cruz A; Ramsey S; Dickson CJ; Duca JS; Hornak V; Koes DR; Kurtzman T Hidden Bias in the DUD-E Dataset Leads to Misleading Performance of Deep Learning in Structure-Based Virtual Screening. PLOS ONE 2019, 14 (8), e0220113. 10.1371/journal.pone.0220113. PubMed DOI PMC

Sieg J; Flachsenberg F; Rarey M In Need of Bias Control: Evaluating Chemical Data for Machine Learning in Structure-Based Virtual Screening. J. Chem. Inf. Model. 2019, 59 (3), 947–961. 10.1021/acs.jcim.8b00712. PubMed DOI

Hartshorn MJ; Verdonk ML; Chessari G; Brewerton SC; Mooij WTM; Mortenson PN; Murray CW Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance. J. Med. Chem. 2007, 50 (4), 726–741. 10.1021/jm061277y. PubMed DOI

Warren GL; Do TD; Kelley BP; Nicholls A; Warren SD Essential Considerations for Using Protein–Ligand Structures in Drug Discovery. Drug Discov. Today 2012, 17 (23), 1270–1281. 10.1016/j.drudis.2012.06.011. PubMed DOI

Friedrich N-O; Meyder A; de Bruyn Kops C; Sommer K; Flachsenberg F; Rarey M; Kirchmair J High-Quality Dataset of Protein-Bound Ligand Conformations and Its Application to Benchmarking Conformer Ensemble Generators. J. Chem. Inf. Model. 2017, 57 (3), 529–539. 10.1021/acs.jcim.6b00613. PubMed DOI

Liu Z; Su M; Han L; Liu J; Yang Q; Li Y; Wang R Forging the Basis for Developing Protein–Ligand Interaction Scoring Functions. Acc. Chem. Res. 2017, 50 (2), 302–309. 10.1021/acs.accounts.6b00491. PubMed DOI

Mysinger MM; Carchia M; Irwin John. J.; Shoichet BK. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking. J. Med. Chem. 2012, 55 (14), 6582–6594. 10.1021/jm300687e. PubMed DOI PMC

Rohrer SG; Baumann K Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data. J. Chem. Inf. Model. 2009, 49 (2), 169–184. 10.1021/ci8002649. PubMed DOI

Tran-Nguyen V-K; Jacquemard C; Rognan D LIT-PCBA: An Unbiased Data Set for Machine Learning and Virtual Screening. J. Chem. Inf. Model. 2020, 60 (9), 4263–4273. 10.1021/acs.jcim.0c00155. PubMed DOI

Gori DNP; Alberca LN; Rodriguez S; Alice JI; Llanos MA; Bellera CL; Talevi A LIDeB Tools: A Latin American Resource of Freely Available, Open-Source Cheminformatics Apps. Artif. Intell. Life Sci. 2022, 2, 100049. 10.1016/j.ailsci.2022.100049. DOI

Ibrahim TM; Bauer MR; Boeckler FM Applying DEKOIS 2.0 in Structure-Based Virtual Screening to Probe the Impact of Preparation Procedures and Score Normalization. J. Cheminformatics 2015, 7 (1), 21. 10.1186/s13321-015-0074-6. PubMed DOI PMC

Vogel SM; Bauer MR; Boeckler FM DEKOIS: Demanding Evaluation Kits for Objective in Silico Screening — A Versatile Tool for Benchmarking Docking Programs and Scoring Functions. J. Chem. Inf. Model. 2011, 51 (10), 2650–2665. 10.1021/ci2001549. PubMed DOI

Benson ML; Smith RD; Khazanov NA; Dimcheff B; Beaver J; Dresslar P; Nerothin J; Carlson HA Binding MOAD, a High-Quality Protein–Ligand Database. Nucleic Acids Res. 2008, 36 (suppl_1), D674–D678. 10.1093/nar/gkm911. PubMed DOI PMC

Liu T; Lin Y; Wen X; Jorissen RN; Gilson MK BindingDB: A Web-Accessible Database of Experimentally Determined Protein–Ligand Binding Affinities. Nucleic Acids Res. 2007, 35 (Database issue), D198–D201. 10.1093/nar/gkl999. PubMed DOI PMC

Gaulton A; Bellis LJ; Bento AP; Chambers J; Davies M; Hersey A; Light Y; McGlinchey S; Michalovich D; Al-Lazikani B; Overington JP ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery. Nucleic Acids Res. 2012, 40 (Database issue), D1100–1107. 10.1093/nar/gkr777. PubMed DOI PMC

Kalliokoski T; Kramer C; Vulpetti A; Gedeck P Comparability of Mixed IC₅₀ Data - a Statistical Analysis. PloS One 2013, 8 (4), e61007. 10.1371/journal.pone.0061007. PubMed DOI PMC

Kramer C; Kalliokoski T; Gedeck P; Vulpetti A The Experimental Uncertainty of Heterogeneous Public K(i) Data. J. Med. Chem. 2012, 55 (11), 5165–5173. 10.1021/jm300131x. PubMed DOI

Schindler CEM; Baumann H; Blum A; Böse D; Buchstaller H-P; Burgdorf L; Cappel D; Chekler E; Czodrowski P; Dorsch D; Eguida MKI; Follows B; Fuchß T; Grädler U; Gunera J; Johnson T; Jorand Lebrun C; Karra S; Klein M; Knehans T; Koetzner L; Krier M; Leiendecker M; Leuthner B; Li L; Mochalkin I; Musil D; Neagu C; Rippmann F; Schiemann K; Schulz R; Steinbrecher T; Tanzer E-M; Unzue Lopez A; Viacava Follis A; Wegener A; Kuhn D Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects. J. Chem. Inf. Model. 2020, 60 (11), 5457–5474. 10.1021/acs.jcim.0c00900. PubMed DOI

Tosstorff A; Rudolph MG; Cole JC; Reutlinger M; Kramer C; Schaffhauser H; Nilly A; Flohr A; Kuhn B A High Quality, Industrial Data Set for Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J. Comput. Aided Mol. Des. 2022, 36 (10), 753–765. 10.1007/s10822-022-00478-x. PubMed DOI

Nicholls A; Mobley DL; Guthrie JP; Chodera JD; Bayly CI; Cooper MD; Pande VS Predicting Small-Molecule Solvation Free Energies: An Informal Blind Test for Computational Chemistry. J. Med. Chem. 2008, 51 (4), 769–779. 10.1021/jm070549+. PubMed DOI

Amezcua M; Setiadi J; Mobley DL The SAMPL9 Host–Guest Blind Challenge: An Overview of Binding Free Energy Predictive Accuracy. Phys. Chem. Chem. Phys. 2024, 26 (12), 9207–9225. 10.1039/D3CP05111K. PubMed DOI PMC

Mobley DL; Liu S; Cerutti DS; Swope WC; Rice JE Alchemical Prediction of Hydration Free Energies for SAMPL. J. Comput. Aided Mol. Des. 2012, 26 (5), 551–562. 10.1007/s10822-011-9528-8. PubMed DOI PMC

Amezcua M; Setiadi J; Ge Y; Mobley DL An Overview of the SAMPL8 Host–Guest Binding Challenge. J. Comput. Aided Mol. Des. 2022, 36 (10), 707–734. 10.1007/s10822-022-00462-5. PubMed DOI PMC

Grosjean H; Işık M; Aimon A; Mobley D; Chodera J; von Delft F; Biggin PC SAMPL7 Protein-Ligand Challenge: A Community-Wide Evaluation of Computational Methods against Fragment Screening and Pose-Prediction. J. Comput. Aided Mol. Des. 2022, 36 (4), 291–311. 10.1007/s10822-022-00452-7. PubMed DOI PMC

Dunbar JB Jr.; Smith RD; Damm-Ganamet KL; Ahmed A; Esposito EX; Delproposto J; Chinnaswamy K; Kang Y-N; Kubish G; Gestwicki JE; Stuckey JA; Carlson HA CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys. J. Chem. Inf. Model. 2013, 53 (8), 1842–1852. 10.1021/ci4000486. PubMed DOI PMC

Smith RD; Damm-Ganamet KL; Dunbar JB Jr.; Ahmed A; Chinnaswamy K; Delproposto JE; Kubish GM; Tinberg CE; Khare SD; Dou J; Doyle L; Stuckey JA; Baker D; Carlson HA CSAR Benchmark Exercise 2013: Evaluation of Results from a Combined Computational Protein Design, Docking, and Scoring/Ranking Challenge. J. Chem. Inf. Model. 2016, 56 (6), 1022–1031. 10.1021/acs.jcim.5b00387. PubMed DOI PMC

Dunbar JB Jr.; Smith RD; Yang C-Y; Ung PM-U; Lexa KW; Khazanov NA; Stuckey JA; Wang S; Carlson HA CSAR Benchmark Exercise of 2010: Selection of the Protein–Ligand Complexes. J. Chem. Inf. Model. 2011, 51 (9), 2036–2046. 10.1021/ci200082t. PubMed DOI PMC

Gaieb Z; Liu S; Gathiaka S; Chiu M; Yang H; Shao C; Feher VA; Walters WP; Kuhn B; Rudolph MG; Burley SK; Gilson MK; Amaro RE D3R Grand Challenge 2: Blind Prediction of Protein–Ligand Poses, Affinity Rankings, and Relative Binding Free Energies. J. Comput. Aided Mol. Des. 2018, 32 (1), 1–20. 10.1007/s10822-017-0088-4. PubMed DOI PMC

Gaieb Z; Parks CD; Chiu M; Yang H; Shao C; Walters WP; Lambert MH; Nevins N; Bembenek SD; Ameriks MK; Mirzadegan T; Burley SK; Amaro RE; Gilson MK D3R Grand Challenge 3: Blind Prediction of Protein–Ligand Poses and Affinity Rankings. J. Comput. Aided Mol. Des. 2019, 33 (1), 1–18. 10.1007/s10822-018-0180-4. PubMed DOI PMC

Parks CD; Gaieb Z; Chiu M; Yang H; Shao C; Walters WP; Jansen JM; McGaughey G; Lewis RA; Bembenek SD; Ameriks MK; Mirzadegan T; Burley SK; Amaro RE; Gilson MK D3R Grand Challenge 4: Blind Prediction of Protein–Ligand Poses, Affinity Rankings, and Relative Binding Free Energies. J. Comput. Aided Mol. Des. 2020, 34 (2), 99–119. 10.1007/s10822-020-00289-y. PubMed DOI PMC

Elofsson A Progress at Protein Structure Prediction, as Seen in CASP15. Curr. Opin. Struct. Biol. 2023, 80, 102594. 10.1016/j.sbi.2023.102594. PubMed DOI

Ackloo S; Al-awar R; Amaro RE; Arrowsmith CH; Azevedo H; Batey RA; Bengio Y; Betz UAK; Bologa CG; Chodera JD; Cornell WD; Dunham I; Ecker GF; Edfeldt K; Edwards AM; Gilson MK; Gordijo CR; Hessler G; Hillisch A; Hogner A; Irwin JJ; Jansen JM; Kuhn D; Leach AR; Lee AA; Lessel U; Morgan MR; Moult J; Muegge I; Oprea TI; Perry BG; Riley P; Rousseaux SAL; Saikatendu KS; Santhakumar V; Schapira M; Scholten C; Todd MH; Vedadi M; Volkamer A; Willson TM CACHE (Critical Assessment of Computational Hit-Finding Experiments): A Public–Private Partnership Benchmarking Initiative to Enable the Development of Computational Methods for Hit-Finding. Nat. Rev. Chem. 2022, 6 (4), 287–295. 10.1038/s41570-022-00363-z. PubMed DOI PMC

Berman HM; Westbrook J; Feng Z; Gilliland G; Bhat TN; Weissig H; Shindyalov IN; Bourne PE The Protein Data Bank. Nucleic Acids Res. 2000, 28 (1), 235–242. 10.1093/nar/28.1.235. PubMed DOI PMC

Cappel D; Jerome S; Hessler G; Matter H Impact of Different Automated Binding Pose Generation Approaches on Relative Binding Free Energy Simulations. J. Chem. Inf. Model. 2020, 60 (3), 1432–1444. 10.1021/acs.jcim.9b01118. PubMed DOI

Kuhn B; Haap W; Obst-Sander U; Kramer C; Stahl M What We Learned in 25 Years of Interactive Molecular Design Sessions. ChemMedChem 2021, 16 (18), 2760–2763. 10.1002/cmdc.202100351. PubMed DOI

Landrum GA; Riniker S Combining IC50 or Ki Values from Different Sources Is a Source of Significant Noise. J. Chem. Inf. Model. 2024, 64 (5), 1560–1567. 10.1021/acs.jcim.4c00049. PubMed DOI PMC

Hahn D; Bayly C; Boby ML; Macdonald HB; Chodera J; Gapsys V; Mey A; Mobley D; Benito LP; Schindler C; Tresadern G; Warren G Best Practices for Constructing, Preparing, and Evaluating Protein-Ligand Binding Affinity Benchmarks [Article v1.0]. Living J. Comput. Mol. Sci. 2022, 4 (1), 1497–1497. 10.33011/livecoms.4.1.1497. PubMed DOI PMC

Hakkennes MLA; Buda F; Bonnet S MetalDock: An Open Access Docking Tool for Easy and Reproducible Docking of Metal Complexes. J. Chem. Inf. Model. 2023, 63 (24), 7816–7825. 10.1021/acs.jcim.3c01582. PubMed DOI PMC

Günther J; Hillig RC; Zimmermann K; Kaulfuss S; Lemos C; Nguyen D; Rehwinkel H; Habgood M; Lechner C; Neuhaus R; Ganzer U; Drewes M; Chai J; Bouché L BAY-069, a Novel (Trifluoromethyl)Pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe. J. Med. Chem. 2022, 65 (21), 14366–14390. 10.1021/acs.jmedchem.2c00441. PubMed DOI PMC

Wang DD; Wu W; Wang R Structure-Based, Deep-Learning Models for Protein-Ligand Binding Affinity Prediction. J. Cheminformatics 2024, 16 (1), 2. 10.1186/s13321-023-00795-9. PubMed DOI PMC

Sadybekov AA; Sadybekov AV; Liu Y; Iliopoulos-Tsoutsouvas C; Huang X-P; Pickett J; Houser B; Patel N; Tran NK; Tong F; Zvonok N; Jain MK; Savych O; Radchenko DS; Nikas SP; Petasis NA; Moroz YS; Roth BL; Makriyannis A; Katritch V Synthon-Based Ligand Discovery in Virtual Libraries of over 11 Billion Compounds. Nature 2022, 601 (7893), 452–459. 10.1038/s41586-021-04220-9. PubMed DOI PMC

Lyu J; Wang S; Balius TE; Singh I; Levit A; Moroz YS; O’Meara MJ; Che T; Algaa E; Tolmachova K; Tolmachev AA; Shoichet BK; Roth BL; Irwin JJ Ultra-Large Library Docking for Discovering New Chemotypes. Nature 2019, 566 (7743), 224–229. 10.1038/s41586-019-0917-9. PubMed DOI PMC

Tummino TA; Iliopoulos-Tsoutsouvas C; Braz JM; O’Brien ES; Stein RM; Craik V; Tran NK; Ganapathy S; Liu F; Shiimura Y; Tong F; Ho TC; Radchenko DS; Moroz YS; Rosado SR; Bhardwaj K; Benitez J; Liu Y; Kandasamy H; Normand C; Semache M; Sabbagh L; Glenn I; Irwin JJ; Kumar KK; Makriyannis A; Basbaum AI; Shoichet BK Large Library Docking for Cannabinoid-1 Receptor Agonists with Reduced Side Effects. bioRxiv February 28, 2024, p 2023.02.27.530254. 10.1101/2023.02.27.530254. PubMed DOI PMC

Coleman RG; Carchia M; Sterling T; Irwin JJ; Shoichet BK Ligand Pose and Orientational Sampling in Molecular Docking. PLOS ONE 2013, 8 (10), e75992. 10.1371/journal.pone.0075992. PubMed DOI PMC

Gorgulla C; Boeszoermenyi A; Wang Z-F; Fischer PD; Coote PW; Padmanabha Das KM; Malets YS; Radchenko DS; Moroz YS; Scott DA; Fackeldey K; Hoffmann M; Iavniuk I; Wagner G; Arthanari H An Open-Source Drug Discovery Platform Enables Ultra-Large Virtual Screens. Nature 2020, 580 (7805), 663–668. 10.1038/s41586-020-2117-z. PubMed DOI PMC

Beroza P; Crawford JJ; Ganichkin O; Gendelev L; Harris SF; Klein R; Miu A; Steinbacher S; Klingler F-M; Lemmen C Chemical Space Docking Enables Large-Scale Structure-Based Virtual Screening to Discover ROCK1 Kinase Inhibitors. Nat. Commun. 2022, 13 (1), 6447. 10.1038/s41467-022-33981-8. PubMed DOI PMC

Gryniukova A; Kaiser F; Myziuk I; Alieksieieva D; Leberecht C; Heym PP; Tarkhanova OO; Moroz YS; Borysko P; Haupt VJ AI-Powered Virtual Screening of Large Compound Libraries Leads to the Discovery of Novel Inhibitors of Sirtuin-1. J. Med. Chem. 2023, 66 (15), 10241–10251. 10.1021/acs.jmedchem.3c00128. PubMed DOI

Gentile F; Yaacoub JC; Gleave J; Fernandez M; Ton A-T; Ban F; Stern A; Cherkasov A Artificial Intelligence–Enabled Virtual Screening of Ultra-Large Chemical Libraries with Deep Docking. Nat. Protoc. 2022, 17 (3), 672–697. 10.1038/s41596-021-00659-2. PubMed DOI

Ton A-T; Gentile F; Hsing M; Ban F; Cherkasov A Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds. Mol. Inform. 2020, 39 (8), 2000028. 10.1002/minf.202000028. PubMed DOI PMC

Tropsha A; Isayev O; Varnek A; Schneider G; Cherkasov A Integrating QSAR Modelling and Deep Learning in Drug Discovery: The Emergence of Deep QSAR. Nat. Rev. Drug Discov. 2024, 23 (2), 141–155. 10.1038/s41573-023-00832-0. PubMed DOI

Bedart C; Simoben CV; Schapira M Emerging Structure-Based Computational Methods to Screen the Exploding Accessible Chemical Space. Curr. Opin. Struct. Biol. 2024, 86, 102812. 10.1016/j.sbi.2024.102812. PubMed DOI

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...